Updating national diagnostic reference levels for interventional cardiology and methodological aspects.


Journal

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)
ISSN: 1724-191X
Titre abrégé: Phys Med
Pays: Italy
ID NLM: 9302888

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 12 07 2019
revised: 05 12 2019
accepted: 14 01 2020
pubmed: 8 2 2020
medline: 18 12 2020
entrez: 8 2 2020
Statut: ppublish

Résumé

The aim of this study is to propose national diagnostic reference levels (DRL) for updating in the field of interventional cardiology and to include technical details to help plan optimization. Medical physics experts and interventional cardiologists from 14 hospitals provided patient dose indicators from coronary angiography and percutaneous coronary interventions. Information about X-ray system dose settings and image quality was also provided. The dose values from 30,024 procedures and 26 interventional laboratories were recorded. The national DRLs proposed for coronary angiography and percutaneous coronary interventions were respectively 39 and 78 Gy·cm

Identifiants

pubmed: 32032801
pii: S1120-1797(20)30017-X
doi: 10.1016/j.ejmp.2020.01.014
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

169-175

Informations de copyright

Copyright © 2020 Associazione Italiana di Fisica Medica. Published by Elsevier Ltd. All rights reserved.

Auteurs

Roberto Sánchez (R)

Hospital Clínico San Carlos, Madrid, Spain; Universidad Complutense de Madrid, Spain. Electronic address: robsan03@ucm.es.

Eliseo Vañó (E)

Hospital Clínico San Carlos, Madrid, Spain; Universidad Complutense de Madrid, Spain.

José M Fernández Soto (JM)

Hospital Clínico San Carlos, Madrid, Spain.

Jose Ignacio Ten (JI)

Hospital Clínico San Carlos, Madrid, Spain.

Javier Escaned (J)

Hospital Clínico San Carlos, Madrid, Spain.

Clara Delgado (C)

Hospital Valle de Hebrón, Barcelona, Spain.

Bruno García (B)

Hospital Valle de Hebrón, Barcelona, Spain.

Francisco Carrera Magariño (F)

Hospital Juan Ramón Jiménez, Huelva, Spain.

José Francisco Díaz Fernández (JFD)

Hospital Juan Ramón Jiménez, Huelva, Spain.

Rafael Jesús Martinez Luna (RJM)

Hospital Reina Sofía, Córdoba, Spain.

Miguel Angel Romero Moreno (MAR)

Hospital Reina Sofía, Córdoba, Spain.

Antonio Catalán (A)

Hospital Universitario de Canarias, Sta. Cruz de Tenerife, Spain.

Francisco Bosa Ojeda (FB)

Hospital Universitario de Canarias, Sta. Cruz de Tenerife, Spain.

Francisco Javier Rosales Espizua (FJ)

Hospital Universitario Basurto, Bilbao, Spain.

Jesús Roberto Sáez Moreno (JRS)

Hospital Universitario Basurto, Bilbao, Spain.

Xavier Pifarré (X)

Hospital Puerta de Hierro, Madrid, Spain.

Javier Goicolea (J)

Hospital Puerta de Hierro, Madrid, Spain.

José Manuel Ordiales (JM)

Hospital de Mérida, Badajoz, Spain.

Juan Manuel Nogales (JM)

Hospital Universitario Infanta Cristina, Badajoz, Spain.

Ginés Martinez (G)

Hospital de Mérida, Badajoz, Spain.

Paula García (P)

Hospital de la Princesa, Madrid, Spain.

Amparo Benedicto (A)

Hospital de la Princesa, Madrid, Spain.

Manuel Francisco Rodriguez Castillo (MFR)

Hospital Universitario Valme, Sevilla, Spain.

Luis Pastor Torres (LP)

Hospital Universitario Valme, Sevilla, Spain.

Joan Font (J)

Hospital Universitario Son Espases, Mallorca, Spain.

Armando Bethencourt (A)

Hospital Universitario Son Espases, Mallorca, Spain.

María Jesús Cesteros (MJ)

Hospital de León, Spain.

Armando Pérez (A)

Hospital de León, Spain.

Eduardo Pinar (E)

Hospital Virgen de Arrixaca, Murcia, Spain.

Bonifacio Tobarra (B)

Hospital Virgen de Arrixaca, Murcia, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH